TrialLancet (London, England)2018

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.

Patrick M O'Neil et al.PubMed ↗Publisher ↗

No numbers read from the abstract.